NASA’s new dark energy space telescope can also detect killer asteroids
technologyreview.com·2h ago
AI Research
arXiv CS.AI·Jun 9·5 min read
AI Scientists Are Only as Good as Their Evidence: A Stratified Ablation of Proprietary Data and Reasoning Skills in Drug-Asset Valuation
TL;DR
AI scientists are often judged based on model quality rather than the evidence they access. A controlled study was conducted using a drug-asset valuation agent, comparing a web-only LLM analyst with one enhanced by public structured tools and a detailed valuation playbook.
✦ Why It Matters
Engineers should focus on integrating high-quality evidence sources to improve AI decision-making capabilities.
Key Takeaways
- Incorporate structured tools in AI models.
- Prioritize evidence quality over model complexity.
- Utilize comprehensive playbooks for decision-making.
- Test AI performance with controlled ablation studies.
Full Summary
In the realm of drug-asset valuation, AI scientists typically focus on the capabilities of their models, overlooking the importance of the evidence they utilize. A controlled three-arm ablation study was conducted on a production valuation agent, where one version was a basic web-only large language model (LLM) analyst, while another incorporated public structured tools and a comprehensive 14-dimension valuation playbook.
The study aimed to assess how these enhancements affected the agent's performance in making knowledge-intensive scientific decisions. Findings indicated that the agent with access to structured tools and a detailed playbook outperformed the basic model, demonstrating that the quality of evidence is a critical factor in effective decision-making.
This research highlights the need for AI systems to integrate robust evidence sources to enhance their reasoning capabilities. The implications suggest that engineers should prioritize evidence quality in AI model development.